No one knows what is going on at Starpharma currently and that is reflected in the shareprice.
Over the past ~15-20yrs SPL has claimed that their DEP platform is a game changer and blockbuster! The strategy has always been to show proof of concept by pushing the DEP products through to the completion of Phase 2 Trials.
These trials finished up 6, 5 and 3 months respectively for DEP Iri, Cab & Dox.
What was announced seemed like positive results for all 3.
Here we are though, floundering in the water with the fruits of nearly 20years worth of work seemingly rotting in our hands.
WHERE ARE THE DEALS? IF THERE ARE NO DEALS, WHAT ARE THE NEXT STEPS FOR SPL AND ITS DEP PLATFORM?
If the answer to question two is for SPL to commence more trials then I think that is the death of the company.......
SPL Price at posting:
13.0¢ Sentiment: Hold Disclosure: Held
